exendin-4 tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology The peptide “exedin-4” was first

Read current terms before submitting payment

Recommended USA Supply Use discount code SAVE10 at Peptira checkout

The Department of Veterans Affairs (VA) Office of Inspector General and the National Intellectual Property Rights Coordination Center announced Operation Genuine Valor, an initiative to protect the VA supply chain from counterfeit, unapproved, substandard, and noncompliant medical devices, equipment, and pharmaceuticals

Clinical trials with tirzepatide demonstrate that GIP agonism combined with GLP-1 agonism is safe and effective for weight loss

Dan Med J

Both Saxenda and Wegovy are covered by the NHS for patients that fulfill certain criteria of BMI and/or weight-related comorbidity